NC State makes the list of Top 100 Worldwide Universities Granted U.S. Utility Patents in 2019 Announced

June 2, 2020 | Sasha Campbell

TAMPA, Fla., June 2, 2020 /PRNewswire/ — The Top 100 Worldwide Universities Granted U.S. Utility Patents in 2019 report was released today by the National Academy of Inventors (NAI) and the Intellectual Property Owners Association...

Continue reading "NC State makes the list of Top 100 Worldwide Universities Granted U.S. Utility Patents in 2019 Announced"

NC State Spin-off TreeCo To Breed a Better Forest

June 1, 2020 | Sasha Campbell

A company founded by two NC State researchers is setting out to revolutionize the forestry industry by combining insights from tree genetics with the power of genome editing. North Carolina is part of the nation’s wood...

Continue reading " NC State Spin-off TreeCo To Breed a Better Forest"

A Necessary Filter

April 3, 2020 | Sasha Campbell

There’s no shortage of NC State ingenuity when it comes to combatting shortages of personal protective equipment used by health care workers and first responders. NC State’s Nonwovens Institute (NWI) is using its two research and training...

Continue reading " A Necessary Filter"

Custom Clotting Particles Could Help Heal Chronic Wounds

March 30, 2020 | Sasha Campbell

New technology could transform the way doctors treat chronic wounds, which affect more than 6 million people in the U.S. each year. Chronic wounds, such as diabetic ulcers or deep-tissue burns, are wounds that heal...

Continue reading " Custom Clotting Particles Could Help Heal Chronic Wounds"

NC State Experts on COVID-19

March 18, 2020 | Sasha Campbell

Economy: Mike Walden, William Neal Reynolds Distinguished Professor and Extension Economist, can discuss the effects of COVID-19 on the U.S. economy. See his recent piece in The Conversation here. He can be reached at walden@ncsu.edu or 919.515.4671. Food safety: Ben...

Continue reading "NC State Experts on COVID-19"

NIAID Small Business Workshop 2020

March 3, 2020 | Sasha Campbell

NIAID Small Business Workshop 2020 Hosted by the National Institute of Allergy and Infectious Disease in partnership with North Carolina State University. The StateView Hotel, Autograph Collection 2451 Alumni Drive Raleigh, NC 27606 April 23,...

Continue reading "NIAID Small Business Workshop 2020"

A world first: Triangle’s Locus Biosciences to launch major gene editing trial

January 13, 2020 | Sasha Campbell

RESEARCH TRIANGLE PARK – Morrisville-based Locus Biosciences, a developer of precision antibacterial therapies, will conduct the world’s first clinical trial of a recombinant bacteriophage therapy, a major milestone for the field, the company announced. Locus has opened...

Continue reading "A world first: Triangle’s Locus Biosciences to launch major gene editing trial"

Wade Fulghum named Assistant Vice Chancellor

December 13, 2019 | Sasha Campbell

After a national search, Wade Fulghum has been selected for the position of Assistant Vice Chancellor for Research Commercialization. Wade has served as Interim Executive Director for Research Commercialization since early 2018. He has been...

Continue reading "Wade Fulghum named Assistant Vice Chancellor"

Chancellor speaking at event

NC State Awards 2019 Innovator & Entrepreneur of the Year

November 8, 2019 | Amy Parker

NC State strives to attract top-notch talent to our university. And the driven, dedicated people here consistently turn NC State research into real-world results, launching startups and patenting technologies at a record pace. In turn,...

Continue reading "NC State Awards 2019 Innovator & Entrepreneur of the Year"

Chancellor’s Innovation Fund Helps Turn NC State Research into Real-World Solutions

July 16, 2019 | Sasha Campbell

At NC State, we know discoveries made here can change the world. And this year, six promising projects will receive support from the Chancellor’s Innovation Fund (CIF), helping researchers turn their discoveries into market-ready solutions....

Continue reading "Chancellor’s Innovation Fund Helps Turn NC State Research into Real-World Solutions"

NIRSleep — a startup led by an NC State alumnus, former employee — wins $25,000 in 2019 Lulu eGames

June 4, 2019 | Sasha Campbell

Less than four years ago, Casey Boutwell was a licensing associate for the Office of Research Commercialization, helping NC State faculty take their research from the lab into the marketplace. Now, he’s the CEO of Bionica Labs,...

Continue reading "NIRSleep — a startup led by an NC State alumnus, former employee — wins $25,000 in 2019 Lulu eGames"

NIRvana Sciences Awarded $3 Million Phase IIb SBIR Grant from NIH

April 4, 2019 | Sasha Campbell

NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins, today announced that it has been awarded a $3 Million Phase IIb SBIR grant from the National Institute of Allergy and Infectious Diseases (NIAID)...

Continue reading "NIRvana Sciences Awarded $3 Million Phase IIb SBIR Grant from NIH"

NC State Spinout Locus Biosciences Inks Historic Licensing Deal

February 11, 2019 | Sasha Campbell

NC State provides innovators with a range of programs and services to develop, protect, market and commercialize inventions developed at the university through the licensing of intellectual property or the launch of new companies based...

Continue reading "NC State Spinout Locus Biosciences Inks Historic Licensing Deal"

Howling Cow Ice Cream Available in Harris Teeter Stores

January 11, 2019 | Sasha Campbell

A State Fair and NC State campus delectable treat is now available for the first time in grocery retail locations across parts of the Triangle. Six different flavors of Howling Cow® ice cream can be purchased...

Continue reading "Howling Cow Ice Cream Available in Harris Teeter Stores"

Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics

January 3, 2019 | Sasha Campbell

Locus Biosciences Inc., a biotechnology company developing precision antibacterial therapies, announced today that it has entered into an exclusive collaboration and license agreement with Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to develop, manufacture and commercialize CRISPR-Cas3-enhanced bacteriophage ("crPhage™") products targeting two key bacterial pathogens for the potential treatment of infections of the respiratory tract and other organ systems.  Johnson & Johnson Innovation LLC facilitated the transaction....

Continue reading "Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics"